RAD50 has been described as a predictive factor for the success of chemotherapy in several different cancers, largely deduced from the analysis of RAD50 transcript levels or the presence of loss‐of‐function variants [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22]. This evidence concerns the gene RAD50 and cancer.